01498 PURAPHARM
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.55X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 89.6% | Net Margin | N/A |
Total Debt/Equity | 327.1% | Return on Equity | N/A |
Price/Book | 1.58X | Return on Assets | N/A |
(HKD 0.445) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -35.44 | -106.08 | -120.21 | -121.88 | 31.71 |
---|---|---|---|---|---|
Net Profit Growth (%) | +66.6 | +11.8 | +1.4 | -484.4 | +114.0 |
Earnings Per Share (HKD) | -0.09 | -0.269 | -0.305 | -0.31 | 0.086 |
Earnings Per Share Growth (%) | +66.6 | +11.9 | +1.6 | -462.0 | +109.8 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | 5.20 |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.281 | 0.387 | 0.652 | 1.017 | 1.296 |
Auditors' Opinion | Unqualified # | Unqualified # | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 172.295 | 207.627 | -17.0 | 195.081 |
Operating Result | -20.486 | -14.616 | +40.2 | -36.514 |
Associates | 0 | -0.149 | -100.0 | 0 |
Profit Before Taxation | -20.486 | -14.765 | +38.7 | -36.514 |
Taxation | 1.32 | 3.921 | -66.3 | 1.161 |
Profit /( Loss) After Taxation | -21.806 | -18.686 | +16.7 | -37.675 |
Net Profit | -21.806 | -18.686 | +16.7 | -37.675 |
Earnings Per Share () | -0.0552 | -0.0473 | +16.7 | -0.0952 |
Announcement Date | 2025-08-26 | 2024-08-28 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25